Stockreport

Rani Therapeutics (RANI): Examining Valuation After Landmark Chugai Deal and $60M Funding Boost [Yahoo! Finance]

Rani Therapeutics Holdings, Inc. - Class A  (RANI) 
PDF The deal includes payments tied to development milestones as well as future product commercialization. See our latest analysis for Rani Therapeutics Holdings. Rani T [Read more]